Yuchi Honaker
Impact in
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
-
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 4
- CRISPR and Genetic Engineering 2
- Oncology 7
- CAR-T cell therapy research 5
- Cancer-related Molecular Pathways 2
- Co-authors
- Helen Piwnica‐Worms (5 shared papers)Wen‐Hui Lien (1 shared paper)Mark R. Silvis (1 shared paper)Valeri Vasioukhin (1 shared paper)Peng Li (1 shared paper)Sarah T. Arron (1 shared paper)Tiebang Kang (1 shared paper)Mien‐Chie Hung (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)Science Translational Medicine (2 papers)Blood (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)Molecular Therapy (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Yuchi Honaker
14 papers receiving 645 citations
Peers
Comparison fields: 5 of 66
- Cell Biology 199
- Oncology 219
- Immunology 130
- Molecular Biology 414
- Genetics 101
Countries citing papers authored by Yuchi Honaker
This map shows the geographic impact of Yuchi Honaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchi Honaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchi Honaker more than expected).
Fields of papers citing papers by Yuchi Honaker
This network shows the impact of papers produced by Yuchi Honaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchi Honaker. The network helps show where Yuchi Honaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuchi Honaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 151 | |
| 2 | 2008 | 131 | |
| 3 | 2020 | 90 | |
| 4 | 2017 | 58 | |
| 5 | 2012 | 53 | |
| 6 | 2010 | 50 | |
| 7 | 2022 | 49 | |
| 8 | 2015 | 30 | |
| 9 | 2015 | 26 | |
| 10 | 2023 | 4 | |
| 11 | 2018 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2024 | 0 |
About Yuchi Honaker
Yuchi Honaker is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Epidemiology, having authored 15 papers that have together received 652 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), DNA Repair Mechanisms (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Diabetes and associated disorders (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Cancer-related Molecular Pathways (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cell Biology (199 citations), Oncology (219 citations), Immunology (130 citations), Molecular Biology (414 citations) and Genetics (101 citations). Yuchi Honaker has collaborated with scholars based in United States and France. Frequent co-authors include Helen Piwnica‐Worms, Wen‐Hui Lien, Mark R. Silvis, Valeri Vasioukhin, Peng Li, Sarah T. Arron, Tiebang Kang, Mien‐Chie Hung, Ettore Appella and Yongkun Wei. Their work appears in journals such as Journal of Biological Chemistry, Science Translational Medicine, Blood, Molecular Therapy — Methods & Clinical Development and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.